Dr. Mark L. Allen, M.D.
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- University of Texas Medical School at San Antonio (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 861
Licensed in Texas since 1992, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: University of Texas Medical School at San Antonio
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
TX license J1610 (first issued 1992; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Medical City Plano Plano, TX
- Baylor Scott & White Medical Center Plano Plano, TX
- Baylor Scott & White Medical Center - Frisco Frisco, TX
Medical groups
- North Dallas Urology Associates (12 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 861
- Services billed
- 8,689
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Bcg live intravesical instillation, 1 mg | 4,150 | 13 |
| Urinalysis, manual test | 1,224 | 724 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,052 | 713 |
| Detection test by nucleic acid for organism, amplified probe technique | 312 | 20 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 295 | 32 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 158 | 56 |
| Diagnostic exam of bladder and urethra using an endoscope | 125 | 95 |
| Detection test for candida species (yeast), amplified probe technique | 120 | 20 |
| Ultrasound measurement of bladder capacity after voiding | 116 | 78 |
| New patient office or other outpatient visit, 30-44 minutes | 93 | 93 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Plano, TX | 1,276 |
| Finasteride Other prescribers in Plano, TX | 785 |
| Levofloxacin Other prescribers in Plano, TX | 136 |
| Gemtesa (vibegron) Other prescribers in Plano, TX | 98 |
| Myrbetriq (mirabegron) Other prescribers in Plano, TX | 98 |
| Testosterone Cypionate Other prescribers in Plano, TX | 97 |
| Alfuzosin Hcl Er (alfuzosin hcl) Other prescribers in Plano, TX | 91 |
| Solifenacin Succinate Other prescribers in Plano, TX | 85 |
| Dutasteride Other prescribers in Plano, TX | 76 |
| Anastrozole Other prescribers in Plano, TX | 70 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 17 companies reported 36 payments worth $970 in total to this clinician.
| Boston Scientific Corporation | $219 |
|---|---|
| Verity Pharmaceuticals Inc. | $109 |
| AbbVie Inc. | $101 |
| Olympus America Inc. | $59.71 |
| Pfizer Inc. | $59.29 |
| Sumitomo Pharma America, Inc. | $51.91 |
| Endo USA, Inc. | $45.27 |
| Profound Medical Corp. | $44.11 |
| Food and Beverage | $935 |
|---|---|
| Education | $35.06 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP Nov 19, 2025 | Education IMFINZI · Oncology · in-kind Company’s descriptionJournal Article | $35.06 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.